Literature DB >> 2175221

Turnover of *I-protein C inhibitor and *I-alpha 1-antitrypsin and their complexes with activated protein C.

M Laurell1, J Stenflo, T H Carlson.   

Abstract

The rates of clearance and catabolism of human protein C inhibitor (PCI) and human alpha 1-antitrypsin (alpha 1-AT) and their complexes with human activated protein C (APC) were studied in the rabbit. The radioiodinated-free inhibitors had biologic half-lives of 23.4 and 62.1 hours, respectively, while the corresponding *I-labeled activated-protein C complexes were cleared with half-lives of 19.6 +/- 3.1 and 72.2 +/- 6.1 minutes. Complex clearances were linked to their catabolism as shown by a correlation between clearance and the appearance of free radioiodine in the plasma. Thus, the difference in the rates of catabolism would result in a fivefold greater amount of alpha 1-AT-APC complex than PCI-APC complex 1 hour after the formation of equal amounts of these in vivo. These results lead to the conclusion that the relative contribution of PCI and alpha 1-AT to the physiologic inhibition of APC cannot be determined only from the rates of the formation of these complexes in vitro, or from measurement of their levels in plasma. The APC-PCI complex is unstable as compared with the APC-alpha 1-AT complex, compounding the problem of estimating rates of complex formation from their levels in plasma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175221

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.

Authors:  Johan Undén; Karin Strandberg; Jan Malm; Eric Campbell; Lars Rosengren; Johan Stenflo; Bo Norrving; Bertil Romner; Arne Lindgren; Gunnar Andsberg
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

2.  Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells.

Authors:  Ernst Böhm; Birgit K Seyfried; Michael Dockal; Michael Graninger; Meinhard Hasslacher; Marianne Neurath; Christian Konetschny; Peter Matthiessen; Artur Mitterer; Friedrich Scheiflinger
Journal:  BMC Biotechnol       Date:  2015-09-18       Impact factor: 2.563

Review 3.  Intracellular and extracellular serpins modulate lung disease.

Authors:  D J Askew; G A Silverman
Journal:  J Perinatol       Date:  2008-12       Impact factor: 2.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.